Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
89 participants
INTERVENTIONAL
2022-08-09
2028-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Position at Birth,Placental Transfusion Volume and Cord Clamping
NCT01497340
Effect of Supine or Prone Position After Caesarean Birth
NCT01310153
Prone or Supine Effect After Caesarean Delivery on Respiratory Outcomes in Full Term Infants
NCT02692573
Delayed Cord Clamping in Preterm Neonates
NCT02478684
Delayed Cord Clamping in VLBW Infants
NCT01222364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prone Positioning During Delayed Cord Clamping
Newborns delivered between 25w+0d and 29w+6d gestation who have been randomized in 1:1 fashion to prone positioning during routine delayed cord clamping.
Prone Positioning
Newborn will be prone position for 30-60 seconds during delayed umbilical cord clamping
Supine Positioning During Delayed Cord Clamping
Newborns delivered between 25w+0d and 29w+6d gestation who have been randomized in 1:1 fashion to supine positioning during routine delayed cord clamping.
Supine Positioning
Newborn will be supine position for 30-60 seconds during delayed umbilical cord clamping
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prone Positioning
Newborn will be prone position for 30-60 seconds during delayed umbilical cord clamping
Supine Positioning
Newborn will be supine position for 30-60 seconds during delayed umbilical cord clamping
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anticipated gestational age of delivery could be between 25w+0d - 29w+6d
* Fetus without major anomalies or known genetic condition that could impact respiratory status or need for intubation at birth
* Singleton or twin gestation
* Neonate eligible for delayed cord clamping based on institutional protocol
* Patient is able to understand study procedures and is willing and able to consent
Exclusion Criteria
* Maternal or fetal/neonatal contraindication to delayed cord clamping
* Major fetal anomaly that would be expected to impact delivery room intubation rates such as:
* Major congenital cardiac defect (not isolated atrial septal defect/ventricular septal defect)
* Significant fetal arrhythmia at the time of delivery
* Fetal tumor
* Renal anhydramnios (not isolated urinary tract dilation with normal fluid)
* Congenital Diaphragmatic Hernia
* Heterotaxy
* Moderate to severe ventriculomegaly or other major brain malformation (not mild isolated ventriculomegaly)
* Airway obstruction
* Underlying genetic disease that could impact respiratory function at delivery
* Arthrogryposis (not apparently isolated clubbed foot)
* Skeletal dysplasia
* Pregnant patient is unable to understand study materials or is unwilling or unable to consent
* Acute maternal obstetric emergency that precludes time or maternal focus for the consent process to take place
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
West Penn Allegheny Health System
OTHER
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katelyn Uribe, MD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins University
Baltimore, Maryland, United States
West Penn Hospital-Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00307467
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.